We have an exciting schedule to offer attendees. Featured sessions this year are:
- COVID-19’s Effect on Standard Access to Care, and Now Access to Vaccinations
- The Life Long Care Costs of Sickle Cell Disease on Caregivers and Individuals, focusing on disability and joblessness
- The Patient Symposium: “A Tale of Two Pandemics,” focusing on the Sickle Cell Disease crisis that was exacerbated with COVID-19.
- Updates from the recipients of the Access to Excellent Care for Sickle Cell Disease Grant Program, funded by Global Blood Therapeutics. Recipients are from: Augusta University’s Sickle Cell Transition Program, Atrium Health Foundation, East Carolina University, OSF Healthcare Saint Francis Medical Center, and the University of Rochester Medical Center.
- The Global Status of Sickle Cell Disease Symposium
- Real World Experience of Biomarkers and New Therapeutics
- Trauma-Informed Care, including Socioeconomic Status, Family Trauma, and Health Inequities
- Post-Transplant Care
- The Clinical Implications of COVID-19 on Sickle Cell Disease
- Genomics and Gene Therapy
- Investigational New Drug, Device and Therapeutics Symposium
- Top Abstract Presentations, Abstract Breakout Sessions and an all-day Poster Session
Abstract and Manuscript submissions for this Symposium are accepted until March 29, 2021.
We are also accepting LATE-BREAKING ABSTRACTS. The deadline is to be announced in the coming weeks.